Danish insulin giant Novo Nordisk has made a 104 million euros investment in new laboratories…
Although type 1 and type 2 diabetes have a huge impact on millions of people worldwide, there is still no cure for either condition. In diabetes, blood sugar levels are dysregulated. If untreated, high levels of blood sugar cause a range of symptoms that can have severe long-term effects. While treatments nowadays can help diabetics manage their symptoms, patients still face many long-term health complications.
Moreover, estimations suggest that the number of people affected by diabetes is steadily increasing worldwide. As a result, the World Health Organization considers diabetes an epidemic. Read on to gather more information about diabetes and how researchers are working on tackling the disease.
Editor's Picks for Diabetes
- The Future of Diabetes Treatment: Is a Cure Possible?
- Needle-Free Diabetes Care: 7 Devices that Painlessly Monitor Blood Sugar
- How Immunotherapy Could Stop and Prevent Type 1 Diabetes
- How the DIY Diabetes Community Made the Artificial Pancreas Possible
- The Three Steps Needed to Fully Automate the Artificial Pancreas
European Biotech Industry Report 2021
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations.
Go to Report
Latest Diabetes Articles
Denmark's Novo Nordisk, the world's largest insulin seller, is betting on a new way to stay…
The European Commission granted marketing authorisation to Eli Lilly and Company and Boehringer Ingelheim for…
Adocia announced today the initiation of a clinical Phase III study in India of BioChaperone…
KalVista Pharmaceuticals, an ophthalmology company with a focus on diabetic macular edema (DME), today announces…